Filing Details
- Accession Number:
- 0001567619-21-001342
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-21 17:06:18
- Reporting Period:
- 2021-01-19
- Accepted Time:
- 2021-01-21 17:06:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1656634 | Gritstone Oncology Inc. | GRTS | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754293 | Roman Yelensky | C/O Gritstone Oncology, Inc. 5959 Horton Street, Suite 300 Emeryville CA 94608 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-19 | 10,000 | $22.10 | 133,224 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $22.00 to $22.40 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
